These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 27255147)
1. 17β-Estradiol Reverses Leptin-Inducing Ovarian Cancer Cell Migration by the PI3K/Akt Signaling Pathway. Hoffmann M; Fiedor E; Ptak A Reprod Sci; 2016 Nov; 23(11):1600-1608. PubMed ID: 27255147 [TBL] [Abstract][Full Text] [Related]
2. Cooperation of bisphenol A and leptin in inhibition of caspase-3 expression and activity in OVCAR-3 ovarian cancer cells. Ptak A; Rak-Mardyła A; Gregoraszczuk EL Toxicol In Vitro; 2013 Sep; 27(6):1937-43. PubMed ID: 23850738 [TBL] [Abstract][Full Text] [Related]
3. Bisphenol A induce ovarian cancer cell migration via the MAPK and PI3K/Akt signalling pathways. Ptak A; Hoffmann M; Gruca I; Barć J Toxicol Lett; 2014 Sep; 229(2):357-65. PubMed ID: 24997338 [TBL] [Abstract][Full Text] [Related]
4. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway. Yousif NG Cell Biol Int; 2014 Jan; 38(1):85-91. PubMed ID: 24115647 [TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells. Whitley BR; Beaulieu LM; Carter JC; Church FC Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899 [TBL] [Abstract][Full Text] [Related]
6. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Saxena NK; Sharma D; Ding X; Lin S; Marra F; Merlin D; Anania FA Cancer Res; 2007 Mar; 67(6):2497-507. PubMed ID: 17363567 [TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone-II increases membrane type I metalloproteinase production via beta-catenin signaling in ovarian cancer cells. Ling Poon S; Lau MT; Hammond GL; Leung PC Endocrinology; 2011 Mar; 152(3):764-72. PubMed ID: 21239435 [TBL] [Abstract][Full Text] [Related]
8. Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells. Kang SK; Choi KC; Tai CJ; Auersperg N; Leung PC Endocrinology; 2001 Feb; 142(2):580-8. PubMed ID: 11159828 [TBL] [Abstract][Full Text] [Related]
9. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53. Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035 [TBL] [Abstract][Full Text] [Related]
10. Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells. Choi JH; Choi KC; Auersperg N; Leung PC Cancer Res; 2006 Apr; 66(7):3912-20. PubMed ID: 16585220 [TBL] [Abstract][Full Text] [Related]
11. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Gao N; Nester RA; Sarkar MA Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414 [TBL] [Abstract][Full Text] [Related]
12. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway. Kim YS; Choi KC; Hwang KA Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941 [TBL] [Abstract][Full Text] [Related]
13. Bisphenol A induces leptin receptor expression, creating more binding sites for leptin, and activates the JAK/Stat, MAPK/ERK and PI3K/Akt signalling pathways in human ovarian cancer cell. Ptak A; Gregoraszczuk EL Toxicol Lett; 2012 May; 210(3):332-7. PubMed ID: 22343039 [TBL] [Abstract][Full Text] [Related]
14. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells. Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418 [TBL] [Abstract][Full Text] [Related]
15. [The effect of leptin and its mechanisms on the migration and invasion of human breast cancer MCF-7 cells]. Wang L; Cao H; Pang X; Li K; Dang W; Tang H; Chen T Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Dec; 29(12):1272-6. PubMed ID: 24321071 [TBL] [Abstract][Full Text] [Related]
16. Leptin promotes human endometriotic cell migration and invasion by up-regulating MMP-2 through the JAK2/STAT3 signaling pathway. Ahn JH; Choi YS; Choi JH Mol Hum Reprod; 2015 Oct; 21(10):792-802. PubMed ID: 26153131 [TBL] [Abstract][Full Text] [Related]
17. p38α MAPK mediates 17β-estradiol inhibition of MMP-2 and -9 expression and cell migration in human lovo colon cancer cells. Hsu HH; Liu CJ; Shen CY; Chen YJ; Chen LM; Kuo WH; Lin YM; Chen RJ; Tsai CH; Tsai FJ; Huang CY J Cell Physiol; 2012 Nov; 227(11):3648-60. PubMed ID: 22377968 [TBL] [Abstract][Full Text] [Related]
18. Sitagliptin Modulates the Response of Ovarian Cancer Cells to Chemotherapeutic Agents. Kosowska A; Garczorz W; Kłych-Ratuszny A; Aghdam MRF; Kimsa-Furdzik M; Simka-Lampa K; Francuz T Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256016 [TBL] [Abstract][Full Text] [Related]
19. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745 [TBL] [Abstract][Full Text] [Related]
20. Pterostilbene carboxaldehyde thiosemicarbazone, a resveratrol derivative inhibits 17β-Estradiol induced cell migration and proliferation in HUVECs. Nikhil K; Sharan S; Wishard R; Palla SR; Krishna Peddinti R; Roy P Steroids; 2016 Apr; 108():17-30. PubMed ID: 26850466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]